Skip to main content
SpringerLink
Log in
Book cover

Anticancer Plants: Natural Products and Biotechnological Implements pp 411–427Cite as

Platelet-Derived Growth Factor Receptor (PDGF-R) as the Target for Herbal-Based Anticancer Agents

  • Chapter
  • First Online:

  • 1215 Accesses

Abstract

In the preceding few years, there has been an exponential development in the field of herbal medicine against cancers due to their natural origin and relatively less adverse reactions than chemotherapy. For quite some time, plant-based molecules have been a source of therapeutic agents, and they keep on playing a crucial part as new investigational drugs against different illnesses including malignancy. The herbal products interact with a wide assortment of proteins, for example, catalysts, transcription factors, inflammatory cytokines, and gene products, correlated with cancer cell survival, invasion, proliferation, migration, and angiogenesis. Most fatal illnesses are caused by alterations of nearly 500 unique genes. The vast group of protein tyrosine kinase functions as a component of signaling pathways and tends to be fundamental for the transforming activity of normal cells into cancerous cells. In which, platelet-derived growth factor receptor (PDGF-R) has a prominent part in the initiation of cell signaling pathways. Platelet-derived growth factor (PDGF) isoforms and their receptors play a vital role in the direction of development and survival of cancer cells. In diseased condition, upgraded motioning of this receptor is the trademark. In particular cases, the persistence of PDGF signaling is fundamental to the survival of malignant cells. Thus, hindrance of PDGF receptor signaling has turned out to be valuable for curing patients with certain rare tumors. The advancement of receptor tyrosine kinase inhibitors that can obstruct diseases caused by abnormalities in this signaling pathway is considered as a promising methodology for the drug development. These drug revelation endeavors have created inhibitors and low molecular weight therapeutics coordinated against the ATP-restricting locales of protein kinases. The aim of this chapter is to discuss the production of plant secondary metabolites that might block tumor metastasis by targeting PDGF-R phosphorylation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bae YS, Sung JY, Kim OS, Kim YJ, Hur KC, Kazlauskas A, Rhee SG (2000) Plateletderived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275:10527–10531

    Article  CAS  PubMed  Google Scholar 

  • Ball SG, Shuttleworth CA, Kielty CM (2007) Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 177:489–500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Banziger-Tobler NE, Halin C, Kajiya K, Detmar M (2008) Growth hormone promotes lymphangiogenesis. Am J Pathol 173:586–597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baxter RM, Secrist JP, Vaillancourt RR, Kazlauskas A (1998) Full activation of the platelet- derived growth factor beta-receptor kinase involves multiple events. J Biol Chem 273:17050–17055

    Article  CAS  PubMed  Google Scholar 

  • Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592–603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bonner JC (2004) Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15:255–273

    Article  CAS  PubMed  Google Scholar 

  • Bonthron DT, Morton CC, Orkin SH, Collins T (1988) Platelet- derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proc Natl Acad Sci USA 85:1492–1496

    Article  CAS  PubMed  Google Scholar 

  • Cao R, Bjorndahl MA, Religa P, Clasper S, Garvin S, Galter D (2004) PDGF-BB induces intra-tumor lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345

    Article  CAS  PubMed  Google Scholar 

  • Cao L, Liu H, Lam DS, Yam GH, Pang CP (2010) In vitro screening for angiostatic potential of herbal chemicals. Invest Ophthalmol Vis Sci 51:6658–6664

    Article  PubMed  Google Scholar 

  • Cao Y, Arbiser J, Amato RJ, Amore PA, Ingber DE, Kerbel R (2011) Forty-year journey of angiogenesis translational research. Sci Transl Med 3:114

    Google Scholar 

  • Center MM, Jemal A, Tieulent LJ, Ward E, Ferlay J, Brawley O, Bray F (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079–1092

    Article  PubMed  Google Scholar 

  • Chan CM, Chang HH, Wang VC, Huang CL, Hung CF (2013) Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRb, PI3K/Akt and MAPK pathways. PLoS One 8:e56819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiara F, Bishayee S, Heldin CH, Demoulin JB (2004) Autoinhibition of the platelet derived growth factor beta- receptor tyrosine kinase by its C-terminal tail. J Biol Chem 279:19732–19738

    Article  CAS  PubMed  Google Scholar 

  • Chou LB, Mann RA, Coughlin MJ, McPeake WT, Mizel MS (2007) Stress fracture as a complication of autogenous bone graft harvest from the distal tibia. Foot Ankle Int 28:199–201

    Article  PubMed  Google Scholar 

  • Daniel EM, Kropnick AS, Heur YH, Blinzler JA, Nims RW, Stoner GD (1990) Extraction, stability, and quantitation of ellagic acid in various fruit and nuts. J Food Compos Anal 2:338–349

    Article  Google Scholar 

  • Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing DJ, Ikejima T (2003) Evodiamine, a constituent of evodiae fructus, induces anti-proliferating effects in tumor cells. Cancer Sci 94:92–98

    Article  CAS  PubMed  Google Scholar 

  • Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498–505

    Article  PubMed  Google Scholar 

  • Folkman J (1990) What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 82:4–6

    Article  CAS  Google Scholar 

  • Fredriksson L, Li H, Fieber C, Li X, Eriksson U (2004a) Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 23:3793–3802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fredriksson L, Li H, Eriksson U (2004b) The PDGF family: four gene products from five dimeric isoforms. Cytokine Growth Factor Rev 15:197–204

    Article  CAS  PubMed  Google Scholar 

  • Fujiki H, Suganuma M, Okabe S (1998) Cancer inhibition by green tea. Mutat Res 402:307–310

    Article  CAS  PubMed  Google Scholar 

  • Gao BB, Hansen H, Chen HC, Feener EP (2006) Angiotensin II stimulates phosphorylation of an ectodomain-truncated platelet-derived growth factor receptorbeta and its binding to class IA PI3K in vascular smooth muscle cells. Biochem J 397:337–344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gill RS, Hsiung MS, Sum CS, Lavine N, Clark SD, Van Tol HH (2010) The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2. Cell Signal 22:285–290

    Article  CAS  PubMed  Google Scholar 

  • Gotink KJ, Verheul HM (2010) Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action. Angiogenesis 13:1–14

    Article  CAS  PubMed  Google Scholar 

  • Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M (2013) Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381:303–312

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    Article  CAS  Google Scholar 

  • Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC (2000) Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275:15926–15932

    Article  CAS  PubMed  Google Scholar 

  • Heldin CH (2013) Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal 11:97. https://doi.org/10.1186/1478-811X-11-97

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Heldin CH, Ostman A, Ronnstrand L (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378:F79–113

    PubMed  CAS  Google Scholar 

  • Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure – an obstacle in cancer therapy. Nat Rev Cancer 4:806–813

    Article  CAS  PubMed  Google Scholar 

  • Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D (2009) Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res 15:1384–1392

    Article  CAS  PubMed  Google Scholar 

  • Heo SK, Yun HJ, Yi HS, Noh EK, Park SD (2009) Evodiamine and rutaecarpine inhibit migration by light via suppression of NAPDH oxidase activation. J Cell Biochem 107:123–133

    Article  CAS  PubMed  Google Scholar 

  • Jayson GC, Parker GJ, Mullamitha S, Valle JW, Saunders M, Broughton L, Lawrance J, Carrington B, Roberts C, Issa B (2005) Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEgylated di-Fab’, leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 11:973–981

    Article  CAS  Google Scholar 

  • Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon- Cardo C, Beug H, Grunert S (2006) Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116:1561–1570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jensen LD, Cao R, Cao Y (2009) In vivo angiogenesis and lymphangiogenesis models. Curr Mol Med 9:982–991

    Article  CAS  PubMed  Google Scholar 

  • Jiang J, Hu C (2009) Evodiamine: A novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 14:1852–1859

    Article  CAS  PubMed  Google Scholar 

  • Jurek A, Amagasaki K, Gembarska A, Heldin CH, Lennartsson J (2009) Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. J Biol Chem 284:4626–4634

    Article  CAS  PubMed  Google Scholar 

  • Khoshkam V, Chan HL, Lin GH, Mailoa J, Giannobile WV, Wang HL, Oh TJ (2015) Outcomes of regenerative treatment with rhPDGF-BB and rhFGF-2 for periodontal intra-bony defects: a systematic review and meta-analysis. J Clin Periodontol 42:272

    Article  CAS  PubMed  Google Scholar 

  • Kim DS, Kwon HM, Choi JS, Kang SW, Ji GE (2007) Resveratrol blunts tumor necrosis factor alpha-induced monocyte adhesion and transmigration. Nutr Res Pract 1:285–290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225

    Article  CAS  PubMed  Google Scholar 

  • Labrecque L, Lamy S, Chapus A, Mihoubi S, Duroche Y, Cass B, Bojanowski MW, Gingras D, Beliveau R (2005) Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26:821–826

    Article  CAS  PubMed  Google Scholar 

  • Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117–1134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu Z, Butow RA (2006) Mitochondrial retrograde signaling. Annu Rev Genet 40:159–185

    Article  CAS  PubMed  Google Scholar 

  • Lu K, Bhat M, Basu S (2016) Plants and their active compounds: natural molecules to target angiogenesis. Angiogenesis 19:287–295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW (2002) Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteasome pathway in prostate cancer cells. Cancer Res 62:2478–2482

    PubMed  CAS  Google Scholar 

  • Martel MD, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615

    Article  PubMed  Google Scholar 

  • Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T (2005) Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol 11:3368–3374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mihaly Z, Sztupinszki Z, Surowiak P, Gyorffy B (2012) A comprehensive overview of targeted therapy in metastatic renal cell carcinoma. Curr Cancer Drug Targets 12:857–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mukherjee AK, Basu S, Sarkar N, Ghosh AC (2001) Advances in cancer therapy with plant based natural products. Curr Med Chem 8:1467–1486

    Article  CAS  PubMed  Google Scholar 

  • Omura T, Heldin CH, Ostman A (1997) Immunoglobulin-like domain 4-mediated receptor- receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization. J Biol Chem 272:12676–12682

    Article  CAS  PubMed  Google Scholar 

  • Ostman A (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15:275–286

    Article  CAS  PubMed  Google Scholar 

  • Papetti M, Herman IM (2002) Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282:C947–C970

    Article  CAS  PubMed  Google Scholar 

  • Pennock S, Kazlauskas A (2012) Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol Cell Biol 32:1955–1966

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perros F, Montani D, Dorfmuller P, Gasselin D, Tcherakian C, Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2008) Platelet derived growth factor expression and function in idiopathic pulmonary aterial hypertension. Am J Resp Crit Care Med 178:81–88

    Article  CAS  PubMed  Google Scholar 

  • Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A (2003) PDGF receptors as cancer drug targets. Cancer Cell 3:439–443

    Article  CAS  PubMed  Google Scholar 

  • Ribatti D, Djonov V (2012) Intussusceptive microvascular growth in tumors. Cancer Lett 316:126–131

    Article  CAS  PubMed  Google Scholar 

  • Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674

    Article  CAS  PubMed  Google Scholar 

  • Sakarkar DM, Deshmukh VN (2011) Ethnopharmacological review of traditional medicinal plant for anticancer activity. Int J Pharm Tech 3:298–308

    Google Scholar 

  • Shen J, Vil MD, Zhang H, Tonra JR, Rong LL, Damoci C, Prewett M, Deevi DS, Kearney J, Surguladze D (2007) An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody. Biochem Biophys Res Commun 357:1142–1147

    Article  CAS  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2016) Cancer statistics 2016. CA Cancer J Clin 66:7–30

    Article  Google Scholar 

  • Socinski MA (2011) Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancer. Cancer Treat Rev 37:611–617

    Article  CAS  PubMed  Google Scholar 

  • Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731–737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Torre LA, Bray F, Siegel RL, Ferlay J, Tieulent JL, Jemal A (2015) Global cancer statistics 2012. CA Cancer J Clin 65:87–108

    Article  Google Scholar 

  • Venkatesan B, Valente AJ, Reddy VS, Siwik DA, Chandrasekar B (2009) Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration. Am J Physiol Heart Circ Physiol 297:H874–H886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang T, Wang Y, Kontani Y, Kobayashi Y, Sato Y, Mori N, Yamashita H (2008) Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. Endocrinology 149:358–366

    Article  CAS  PubMed  Google Scholar 

  • Wang CZ, Calway T, Yuan CS (2012) Herbal medicine as adjuvants for cancer therapeutics. Am J Chin Med 40:657–669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang P, Song L, Ge H, Jin P, Jiang Y, Hu W, Geng N (2014) Crenolanib, a PDGFR inhibitor suppresses lung cancer cell proliferation and inhibits tumor growth in vivo. Oncol Targets Ther 7:1761–1768

    Article  CAS  Google Scholar 

  • Wardega P, Heldin CH, Lennartsson J (2010) Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration. Cell Signal 22:1363–1368

    Article  CAS  PubMed  Google Scholar 

  • Weber AA, Neuhaus T, Skach RA, Hescheler J, Ahn HY, Schror K, Ko Y, Sachinidis A (2004) Mechanism of the inhibitory effects of epigallocatechin-3 gallate on platelet – derived growth factor-BB induced cell signaling and mitogenesis. FASEB J 18:128–130

    Article  CAS  PubMed  Google Scholar 

  • Weinstein IB, Joe A (2008) Oncogene addiction. Cancer Res 68:3077–3080

    Article  CAS  PubMed  Google Scholar 

  • Weiss L (2000) Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev 19:193–400

    Article  Google Scholar 

  • Wilhelm SM, Carter C, Tang L (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the Raf/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64:7099–7109

    Article  CAS  PubMed  Google Scholar 

  • Yang Y, Yuzawa S, Schlessinger J (2008a) Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization. Proc Natl Acad Sci USA 105:7681–7686

    Article  PubMed  Google Scholar 

  • Yang J, Wu LJ, Tashiro S, Onodera S, Ikejima T (2008b) Nitric oxide activated by p38 and NF- kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells. Free Radic Res 42:1–11

    Article  CAS  PubMed  Google Scholar 

  • Yang G, Li X, Li X, Wang L, Li J, Song X (2012) Traditional Chinese medicine in cancer care: a review of case series published in the Chinese literature. Evid Based Complement Alternat Med 2012:751046. https://doi.org/10.1155/2012/751046

    Article  PubMed  PubMed Central  Google Scholar 

  • Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P (2013) Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof in hepatocellular carcinoma cells. Cancer Lett 328:243–251

    Article  CAS  PubMed  Google Scholar 

  • Yehya AHS, Asif M, Tan YJ, Sasidharan S, Majid AMSA, Einoon C (2017) Broad spectrum targeting of tumor vasculature by medicinal plants: An updated review. J Herbal Med. https://doi.org/10.1016/j.hermed.2017.03.003

  • Zheng S, Chen A (2006) Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290:G883–G893

    Article  CAS  PubMed  Google Scholar 

  • Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541

    PubMed  CAS  Google Scholar 

  • Zhou Y, Zheng S, Lin J, Zhang QJ, Chen A (2007) The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPAR gamma in rat activated hepatic stellate cell in vitro. Lab Investig 5:488–498

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Plant Biotechnology, School of Biotechnology, Madurai Kamaraj University, Madurai, Tamil Nadu, India

    Manjula Devi Ramamoorthy & Kannan Narayanan Dhiraviam

Authors
  1. Manjula Devi Ramamoorthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kannan Narayanan Dhiraviam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kannan Narayanan Dhiraviam .

Editor information

Editors and Affiliations

  1. Department of Botany, Gandhi Faiz-e-Aam College, Shahjahanpur, Uttar Pradesh, India

    Mohd Sayeed Akhtar

  2. Department of Crop Science, Faculty of Agriculture, Universiti Putra Malaysia, Serdang, Selangor, Malaysia

    Mallappa Kumara Swamy

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ramamoorthy, M.D., Dhiraviam, K.N. (2018). Platelet-Derived Growth Factor Receptor (PDGF-R) as the Target for Herbal-Based Anticancer Agents. In: Akhtar, M., Swamy, M. (eds) Anticancer Plants: Natural Products and Biotechnological Implements. Springer, Singapore. https://doi.org/10.1007/978-981-10-8064-7_17

Download citation

Publish with us

Policies and ethics

Search

Navigation